Arcus Biosciences, Inc.·4

Dec 18, 7:58 PM ET

PERLMAN ANDREW J 4

4 · Arcus Biosciences, Inc. · Filed Dec 18, 2020

Insider Transaction Report

Form 4
Period: 2020-12-17
Transactions
  • Award

    Common Stock

    2020-12-17+4,5004,500 total
  • Award

    Stock Option (Right to Buy)

    2020-12-17+21,00021,000 total
    Exercise: $31.77Exp: 2030-12-16Common Stock (21,000 underlying)
Holdings
  • Common Stock

    2,525
Footnotes (2)
  • [F1]Represents the grant of restricted stock units that vest in three equal annual installments on each of December 15, 2021, December 15, 2022 and December 15, 2023, subject to the Reporting Person's continued service to the Company.
  • [F2]The option is exercisable in 36 equal monthly installments after December 17, 2020, subject to the Reporting Person's continued service to the Company.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_951236

    POA DOCUMENT